Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Graves Disease Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of hyperthyroidism disease
5.1.1.2. Rising awareness regarding disease among the population
5.1.1.3. Government initiatives to improve disease treatment
5.1.2. Restraints
5.1.2.1. Concern with serious complication associated with disease
5.1.3. Opportunities
5.1.3.1. Surging research and development of grave disease treatment
5.1.3.2. Availability of new radioiodine therapy and medications
5.1.4. Challenges
5.1.4.1. Increasing recalls of thyroid drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Graves Disease Market, by Treatment
6.1. Introduction
6.2. Anti-Thyroid Medication
6.3. Radioactive Iodine Therapy
6.4. Surgery

7. Graves Disease Market, by Diagnosis
7.1. Introduction
7.2. Blood Sample
7.3. Imaging Tests
7.4. Radioactive Iodine Uptake
7.5. Ultrasound

8. Americas Graves Disease Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Graves Disease Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Graves Disease Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. AbbVie Inc.
12.1.3. Amgen Inc.
12.1.4. Bayer AG
12.1.5. Eli Lilly and Company
12.1.6. F. Hoffmann-La Roche Ltd.
12.1.7. Horizon Therapeutics PLC
12.1.8. Immunovant, Inc.
12.1.9. Lupin Limited
12.1.10. Medtronic PLC
12.1.11. Merck KGaA
12.1.12. Mylan N.V.
12.1.13. Pfizer, Inc.
12.1.14. RLC Labs, Inc.
12.1.15. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. GRAVES DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GRAVES DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GRAVES DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GRAVES DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GRAVES DISEASE MARKET DYNAMICS
FIGURE 7. GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
FIGURE 10. GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. GRAVES DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. GRAVES DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. GRAVES DISEASE MARKET SIZE, BY ANTI-THYROID MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GRAVES DISEASE MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 10. GRAVES DISEASE MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GRAVES DISEASE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 21. CANADA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. CANADA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 23. MEXICO GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. MEXICO GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 33. CHINA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. CHINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 35. INDIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 36. INDIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 39. JAPAN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. JAPAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 51. THAILAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. THAILAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. DENMARK GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 60. EGYPT GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. EGYPT GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. FINLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. FINLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 64. FRANCE GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. FRANCE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 66. GERMANY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. GERMANY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 70. ITALY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. ITALY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 76. NORWAY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. NORWAY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 78. POLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. POLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 80. QATAR GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. QATAR GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 88. SPAIN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. SPAIN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 94. TURKEY GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. TURKEY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 100. GRAVES DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. GRAVES DISEASE MARKET LICENSE & PRICING